-
Zhongguo Shi Yan Xue Ye Xue Za Zhi · Dec 2014
Review[Treatment of lymphoblastic leukemia with CD19-specific modified chimeric antigen receptor T cells].
- Huan-Huan Li, Ping Zhu, Xue-Qiang Wu, and Yu-Feng Liu.
- Hematology & Oncology Institute,Beijing Aerospace General Hospital, Beijing 100076, China; Department of Pediatrics, The Fist Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.
- Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Dec 1;22(6):1753-6.
AbstractBioengineered T cells, which are the genetically manipulated T cells to express chimeric antigen receptor T Cell (CAR T) against leukemia-associated specific antigens, were applied to treat acute and chronic lymphocytic leukemia with CAR T. CAR T cells combined with cell-surface binding site and anti-CD19 chimeric antigen receptor can treat diseases through T cells transfection. CAR T cells can recognize the CD19 antigen on B cells with specific cell-surface loci. CAR T cells can proliferate by 1000 times and differentiate in vivo by the CD19 antigen stimulation, therefore, kill the acute and chronic lymphocytic leukemia cells effectively. This article briefly reviews the CAR T cells and the effect of CAR T cells on acute and chronic lymphoblastic leukemia.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.